266 related articles for article (PubMed ID: 26651603)
1. Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.
Ring KL; An MC; Zhang N; O'Brien RN; Ramos EM; Gao F; Atwood R; Bailus BJ; Melov S; Mooney SD; Coppola G; Ellerby LM
Stem Cell Reports; 2015 Dec; 5(6):1023-1038. PubMed ID: 26651603
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
3. Reversal of cellular phenotypes in neural cells derived from Huntington's disease monkey-induced pluripotent stem cells.
Carter RL; Chen Y; Kunkanjanawan T; Xu Y; Moran SP; Putkhao K; Yang J; Huang AH; Parnpai R; Chan AW
Stem Cell Reports; 2014 Oct; 3(4):585-93. PubMed ID: 25358787
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
5. Systems Genetic Analyses Highlight a TGFβ-FOXO3 Dependent Striatal Astrocyte Network Conserved across Species and Associated with Stress, Sleep, and Huntington's Disease.
Scarpa JR; Jiang P; Losic B; Readhead B; Gao VD; Dudley JT; Vitaterna MH; Turek FW; Kasarskis A
PLoS Genet; 2016 Jul; 12(7):e1006137. PubMed ID: 27390852
[TBL] [Abstract][Full Text] [Related]
6. Stem cell therapy and cellular engineering for treatment of neuronal dysfunction in Huntington's disease.
Choi KA; Hwang I; Park HS; Oh SI; Kang S; Hong S
Biotechnol J; 2014 Jul; 9(7):882-94. PubMed ID: 24827816
[TBL] [Abstract][Full Text] [Related]
7. Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.
An MC; Zhang N; Scott G; Montoro D; Wittkop T; Mooney S; Melov S; Ellerby LM
Cell Stem Cell; 2012 Aug; 11(2):253-63. PubMed ID: 22748967
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
9. FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.
Liu Y; Qiao F; Leiferman PC; Ross A; Schlenker EH; Wang H
Hum Mol Genet; 2017 Nov; 26(22):4416-4428. PubMed ID: 28973411
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Development Corrected in Adult-Onset Huntington's Disease iPSC-Derived Neuronal Cultures via WNT Signaling Modulation.
Smith-Geater C; Hernandez SJ; Lim RG; Adam M; Wu J; Stocksdale JT; Wassie BT; Gold MP; Wang KQ; Miramontes R; Kopan L; Orellana I; Joy S; Kemp PJ; Allen ND; Fraenkel E; Thompson LM
Stem Cell Reports; 2020 Mar; 14(3):406-419. PubMed ID: 32109367
[TBL] [Abstract][Full Text] [Related]
11. Aberrant transcriptional networks in step-wise neurogenesis of paroxysmal kinesigenic dyskinesia-induced pluripotent stem cells.
Li C; Ma Y; Zhang K; Gu J; Tang F; Chen S; Cao L; Li S; Jin Y
Oncotarget; 2016 Aug; 7(33):53611-53627. PubMed ID: 27449084
[TBL] [Abstract][Full Text] [Related]
12. Use of human stem cells in Huntington disease modeling and translational research.
Golas MM; Sander B
Exp Neurol; 2016 Apr; 278():76-90. PubMed ID: 26826449
[TBL] [Abstract][Full Text] [Related]
13. Huntington disease iPSCs show early molecular changes in intracellular signaling, the expression of oxidative stress proteins and the p53 pathway.
Szlachcic WJ; Switonski PM; Krzyzosiak WJ; Figlerowicz M; Figiel M
Dis Model Mech; 2015 Sep; 8(9):1047-57. PubMed ID: 26092128
[TBL] [Abstract][Full Text] [Related]
14. Induced Pluripotent Stem Cells in Huntington's Disease Research: Progress and Opportunity.
Tousley A; Kegel-Gleason KB
J Huntingtons Dis; 2016 Jun; 5(2):99-131. PubMed ID: 27372054
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.
HD iPSC Consortium
Cell Stem Cell; 2012 Aug; 11(2):264-78. PubMed ID: 22748968
[TBL] [Abstract][Full Text] [Related]
16. Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes.
Conforti P; Besusso D; Bocchi VD; Faedo A; Cesana E; Rossetti G; Ranzani V; Svendsen CN; Thompson LM; Toselli M; Biella G; Pagani M; Cattaneo E
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E762-E771. PubMed ID: 29311338
[TBL] [Abstract][Full Text] [Related]
17. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
[TBL] [Abstract][Full Text] [Related]
18. Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells.
Feyeux M; Bourgois-Rocha F; Redfern A; Giles P; Lefort N; Aubert S; Bonnefond C; Bugi A; Ruiz M; Deglon N; Jones L; Peschanski M; Allen ND; Perrier AL
Hum Mol Genet; 2012 Sep; 21(17):3883-95. PubMed ID: 22678061
[TBL] [Abstract][Full Text] [Related]
19. Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease.
Naphade S; Embusch A; Madushani KL; Ring KL; Ellerby LM
Front Neurosci; 2017; 11():736. PubMed ID: 29459817
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
